Zusammenfassung
In den letzten Jahren ist die Anzahl von fMRT-Studien, die die neuralen Effekte von Psychopharmaka untersuchen, enorm gestiegen. Das Kapitel erklärt Sinn und Nutzen solcher pharmakologischer fMRT-Studien und gibt einen Überblick über die wichtigsten Arbeiten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Achard S, Bullmore E (2007) Efficiency and cost of economical brain functional networks. PLoS Comput Biol 3: e17
Bentley P, Driver J, Dolan RJ (2008) Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer‘s disease and health. Brain 131: 409–424
Bentley P, Driver J, Dolan RJ (2011) Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging. Prog Neurobiol 94: 360–388
Bloom AS, Hoffmann RG, Fuller SA, Pankiewicz J, Harsch HH, Stein EA (1999) Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Hum Brain Mapp 8: 235–244
Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 10: 186–198
Bullmore E, Suckling J, Zelaya F, Long C, Honey G, Reed L, Routledge C, Ng V, Fletcher P, Brown J, Williams SC (2003) Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics. Cereb Cortex 13: 144–154
Chamberlain SR, Hampshire A, Müller U, Rubia K, Del CN, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ (2009) Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 65: 550–555
Cools R, Calder AJ, Lawrence AD, Clark L, Bullmore E, Robbins TW (2005) Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology (Berl) 180: 670–679
Coull JT, Nobre AC, Frith CD (2001) The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex 11: 73–84
Coull JT, Jones M, Egan T, Frith CD, Maze M (2004) Noradrenergic a2 attentional effects vary with arousal level: modulation of the thalamic pulvinar in healthy humans. Neuroimage 22: 315–322
Di Simplicio M, Norbury R, Harmer CJ (2012) Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression. Mol Psychiatry 17: 503–510
Furey ML, Pietrini P, Haxby JV (2000) Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315–2319
Giessing C, Fink GR, Rosler F, Thiel CM (2007) fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis. J Cogn Neurosci 19: 658–670
Goekoop R, Scheltens P, Barkhof F, Rombouts SA (2006) Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation – a pharmacological fMRI study. Brain 129: 141–157
Graf H, Abler B, Freudenmann R, Beschoner P, Schaeffeler E, Spitzer M, Schwab M, Gron G (2011) Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biol Psychiatry 69: 890–897
Grefkes C, Wang LE, Eickhoff SB, Fink GR (2009) Noradrenergic Modulation of Cortical Networks Engaged in Visuomotor Processing. Cereb Cortex 20: 783–797
Grön G, Brandenburg I, Wunderlich AP, Riepe MW (2006) Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol. Aging 27: 78–87
Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA (2007) Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 27: 3477–3489
Jocham G, Klein TA, Ullsperger M (2011) Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices. J Neurosci 31: 1606–1613
Kelly C, de Zubicaray G, Di Martino A, Copland DA, Reiss PT, Klein DF, Castellanos FX, Milham MP, McMahon K (2009) L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J Neurosci 29: 7364–7378
Kukolja J, Schlapfer TE, Keysers C, Klingmuller D, Maier W, Fink GR, Hurlemann R (2008) Modeling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions. J Neurosci 28: 12868–12876
Kukolja J, Thiel CM, Fink GR (2009) Cholinergic stimulation enhances neural activity associated with encoding but reduces neural activity associated with retrieval in humans. J Neurosci 29: 8119–8128
Leslie RA, James MF (2000) Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21: 314–318
Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O, Celsis P, Chollet F (2002) A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: doubleblind, plazebo-controlled, fMRI study in healthy subjects. Neuro- Image 15: 26–36
Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 12: 268–275
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186–6191
McCabe C, Mishor Z (2011) Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. Neuroimage. 57: 1317–1323
Morcom AM, Bullmore ET, Huppert FA, Lennox B, Praseedom A, Linnington H, Fletcher PC (2009) Memory Encoding and Dopamine in the Aging Brain: A Psychopharmacological Neuroimaging Study. Cereb Cortex 20: 743–757
Murphy SE, Norbury R, O‘Sullivan U, Cowen PJ, Harmer CJ (2009) Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 194: 535–540
Newhouse PA, Potter AS, Dumas JA, Thiel CM (2011) Functional brain imaging of nicotinic effects on higher cognitive processes. Biochem Pharmacol 82: 943–951
Northoff G, Witzel T, Richter A, Gessner M, Schlagenhauf F, Fell J, Baumgart F, Kaulisch T, Tempelmann C, Heinzel A, Kotter R, Hagner T, Bargel B, Hinrichs H, Bogerts B, Scheich H, Heinze HJ (2002) GABAergic modulation of prefrontal spatio-temporal activation pattern during emotional processing: a combined fMRI/MEG study with Plazebo and lorazepam. J Cogn Neurosci 14: 348–370
Onur OA, Walter H, Schlaepfer TE, Rehme AK, Schmidt C, Keysers C, Maier W, Hurlemann R (2009) Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci 4: 119–126
Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C, Rascol O, Chollet F (2001) Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 50: 718–729
Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442: 1042–1045
Rogers RD (2011) The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharm 36: 114–132
Schunck T, Mathis A, Erb G, Namer IJ, Demazieres A, Luthringer R (2010) Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge. J Psychopharmacol 24: 701–708
Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M (2002 Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci USA 99: 455–460
Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M, Rao SM, Bandettini PA, Bloom AS (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155: 1009–1015
Strange BA, Dolan RJ (2004) Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci USA 101: 11454–11458
Tanabe J, Nyberg E, Martin LF, Martin J, Cordes D, Kronberg E, Tregellas JR (2011) Nicotine effects on default mode network during resting state. Psychopharmacology (Berl) 216: 287–295
Tardy J, Pariente J, Leger A, Dechaumont-Palacin S, Gerdelat A, Guiraud V, Conchou F, Albucher JF, Marque P, Franceries X, Cognard C, Rascol O, Chollet F, Loubinoux I (2006) Methylphenidate modulates cerebral post-stroke reorganization. Neuroimage 33: 913–922
Thiel CM, Fink GR (2008) Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control. Neurosci 152: 381–390
Thiel CM, Henson RN, Morris JS, Friston KJ, Dolan RJ (2001) Pharmacological modulation of behavioural and neuronal correlates of repetition priming. J Neurosci 21: 6846–6852
Thiel CM, Bentley P, Dolan RJ (2002a) Effects of cholinergic enhancement on conditioning-related responses in human auditory cortex. Eur J Neurosci 16:2199–2206
Thiel CM, Friston KJ, Dolan RJ (2002b) Cholinergic modulation of experience-dependent plasticity in human auditory cortex. Neuron 35: 567–574
Thiel CM, Henson RN, Dolan RJ (2002c) Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacol 27: 282–292
Thiel CM, Zilles K, Fink GR (2005) Nicotine modulates reorienting of visuospatial attention and neural activity in parietal cortex. Neuropsychopharmacol 30: 810–820
Vossel S, Thiel CM, Fink GR (2008) Behavioral and neural effects of nicotine on visuospatial attentional reorienting in non-smoking subjects. Neuropsychopharm 33: 731–738
Wang LE, Fink GR, Diekhoff S, Rehme AK, Eickhoff SB, Grefkes C (2011) Noradrenergic enhancement improves motor network connectivity in stroke patients. Ann Neurol 69: 375–388
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thiel, C., Fink, G.R. (2013). Neuropharmakologische funktionelle Bildgebung. In: Schneider, F., Fink, G.R. (eds) Funktionelle MRT in Psychiatrie und Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29800-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-29800-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29799-1
Online ISBN: 978-3-642-29800-4
eBook Packages: Medicine (German Language)